v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
Clinical trial NCT03447990 · COMPLETED
Trial details
- NCT number
- NCT03447990
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2019-10-24
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.